SCHEMBL272872

SCHEMBL272872

O=c1oc(-c2cccc(-c3nc4ccccc4c(=O)o3)c2)nc2ccccc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.83
KMT2A Q03164 8/20 0.74
ALDH1A1 P00352 8/20 0.74
HPGD P15428 4/20 0.74
F2 P00734 2/20 0.74
MEN1 O00255 7/20 0.72
SMN1; SMN2 Q16637 3/20 0.68
TP53 P04637 3/20 0.68
NPC1 O15118 5/20 0.67
RAB9A P51151 4/20 0.67
MAPT P10636 3/20 0.67
LMNA P02545 2/20 0.67
MAPK10 P53779 1/20 0.67
RXFP1 Q9HBX9 1/20 0.67
KDM4E B2RXH2 5/20 0.65
POLB P06746 2/20 0.65
CYP1A2 P05177 2/20 0.62
CYP3A4 P08684 2/20 0.62
CYP2C19 P33261 2/20 0.62
CYP2C9 P11712 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL271965 0.93 ELANE (0.83) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL29444225 0.93 ELANE (0.83) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL272702 0.91 ELANE (1.00) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL29382161 0.91 ELANE (1.00) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL914536 0.89 ELANE (0.71) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL914294 0.89 ELANE (0.71) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL914659 0.89 ELANE (0.71) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL10834171 0.89 ELANE (0.71) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL5921381 0.89 ELANE (0.71) ELANEKMT2AALDH1A1HPGDF2
SCHEMBL757083 0.88 ELANE (0.75) ELANEKMT2AALDH1A1HPGDF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146144-A1 SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION CYTEC INDUSTRIES INC. (US) 2026-05-28 US claimed
WO-2025099141-A1 STABILIZING COMPOSITIONS FOR POLYMERIC MATERIALS CYTEC INDUSTRIES INC. (US) 2025-05-15 WO claimed
WO-2025099143-A1 COMPOSITIONS FOR STABILIZING POLYMERIC MATERIALS AGAINST UV LIGHT THERMAL AND GAS FADING DEGRADATION CYTEC INDUSTRIES INC. (US) 2025-05-15 WO claimed
WO-2025056330-A1 STABILIZED POLYMER COMPOSITIONS WITH IMPROVED COLOR RESISTANCE CYTEC INDUSTRIES INC. (US) 2025-03-20 WO claimed
US-12227635-B2 Stabilizer compositions and methods for using same for protecting polymeric organic materials from UV light and thermal degradation CYTEC INDUSTRIES INC. (US) 2025-02-18 US claimed
EP-4363506-A1 COMPOSITIONS AND METHODS FOR PROTECTING COATINGS FROM THE DELETERIOUS EFFECTS OF EXPOSURE TO UV-C LIGHT Cytec Industries Inc. (US) 2024-05-08 EP claimed
EP-4251690-A1 COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM THE DELETERIOUS EFFECTS EXPOSURE TO UV-C LIGHT Cytec Industries Inc. (US) 2023-10-04 EP claimed
EP-4251689-A1 COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM DISCOLORATION DUE TO EXPOSURE TO UV-C LIGHT Cytec Industries, Inc. (US) 2023-10-04 EP claimed
CN-116783246-A Compositions and methods for protecting organic polymeric materials from discoloration due to exposure to UV-C light 塞特工业公司 2023-09-19 CN claimed
WO-2023278282-A1 COMPOSITIONS AND METHODS FOR PROTECTING COATINGS FROM THE DELETERIOUS EFFECTS OF EXPOSURE TO UV-C LIGHT CYTEC INDUSTRIES INC. (US) 2023-01-05 WO claimed
WO-2022115578-A1 COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM THE DELETERIOUS EFFECTS EXPOSURE TO UV-C LIGHT CYTEC INDUSTRIES INC. (US) 2022-06-02 WO claimed
US-20220169828-A1 COMPOSITIONS AND METHODS FOR PROTECTING ORGANIC POLYMERIC MATERIALS FROM DISCOLORATION DUE TO EXPOSURE TO UV-C LIGHT CYTEC INDUSTRIES INC. (US) 2022-06-02 US claimed
US-20210403690-A1 STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING POLYMERIC ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION CYTEC INDUSTRIES INC. (US) 2021-12-30 US claimed
US-11091615-B2 Stabilizer compositions and methods for using same for protecting organic materials from UV light and thermal degradation CYTEC INDUSTRIES INC. (US) 2021-08-17 US claimed
US-10975278-B2 Granular stabilizer compositions for use in polymer resins and methods of making same CYTEC INDUSTRIES INC. (US) 2021-04-13 US claimed
US-20190264084-A1 GRANULAR STABILIZER COMPOSITIONS FOR USE IN POLYMER RESINS AND METHODS OF MAKING SAME CYTEC INDUSTRIES INC. (US) 2019-08-29 US claimed
US-20160145427-A1 STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION CYTEC INDUSTRIES INC. 2016-05-26 US claimed
US-20040219390-A1 Benzoxazinone and quinazolinone derivatives HONEYWELL INTERNATIONAL, INC. (US) 2004-11-04 US claimed
WO-2004059604-A2 METHOD AND SYSTEM FOR FABRICATING AN OLED HONEYWELL INTERNATIONAL, INC. (US) 2004-07-15 WO claimed
US-20040132228-A1 Method and system for fabricating an OLED HONEYWELL INTERNATIONAL INC. (US) 2004-07-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040219390-A1 Benzoxazinone and quinazolinone derivatives XDH, AOX1, CYP4X1 ELANE 3064/4885KMT2A 3418/4885ALDH1A1 561/4885
US-20260146144-A1 SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION RAD52, XRCC6, RAD23B ELANE 2476/4885KMT2A 2244/4885ALDH1A1 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.